Home
>
National Drug Code (NDC)
>
Anew Clinical
Anew Clinical - 10096-0304-5 - (Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone)
Drug Information of Anew Clinical
| Product NDC: | 10096-0304 |
| Proprietary Name: | Anew Clinical |
| Non Proprietary Name: | Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone |
| Active Ingredient(s): | 28; 95; 75; 25.6; 47.5 mg/g; mg/g; mg/g; mg/g; mg/g & nbsp; Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Anew Clinical
| Product NDC: | 10096-0304 |
| Labeler Name: | Avon Products, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20130522 |
Package Information of Anew Clinical
| Package NDC: | 10096-0304-5 |
| Package Description: | 1.1 g in 1 PACKET (10096-0304-5) |
NDC Information of Anew Clinical
| NDC Code | 10096-0304-5 |
| Proprietary Name | Anew Clinical |
| Package Description | 1.1 g in 1 PACKET (10096-0304-5) |
| Product NDC | 10096-0304 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20130522 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Avon Products, Inc. |
| Substance Name | AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE |
| Strength Number | 28; 95; 75; 25.6; 47.5 |
| Strength Unit | mg/g; mg/g; mg/g; mg/g; mg/g |
| Pharmaceutical Classes |
